FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Yvette Kasamon

Research Profile

Procedures

Concepts & Ideas

Disorders

Chemicals & Drugs

Living Beings

Young Adult

Co-author Network

Publications

TOP 3
Jennifer A Kanakry; Yvette L Kasamon; Leo Luznik; Lode J Swinnen; HEATHER SYMONS; Hua-Ling Tsai; F. JAVIER BOLANOS MEADE; JANICE DAVIS SPROUL; Ephraim J Fuchs; Nilanjan Ghosh; Douglas E Gladstone; Christopher D Gocke; Richard J Jones; Richard F Ambinder
Outcomes of related donor HLA-identical or HLA-haploidentical allogeneic blood or marrow transplantation for peripheral T cell lymphoma.
Douglas E Gladstone; Richard J Jones; Yvette L Kasamon; Karen E King; Robert A Brodsky; Ephraim J Fuchs; Leo Luznik; Andrea A Zachary; Mary S Leffell
Partially mismatched transplantation and human leukocyte antigen donor-specific antibodies.
Amer Zeidan; Joseph Aoki; F. JAVIER BOLANOS MEADE; Michael J Borowitz; Ephraim J Fuchs; Richard J Jones; Yvette L Kasamon; Leo Luznik; Lode J Swinnen; HEATHER SYMONS; Richard F Ambinder
Human leukocyte antigen-haploidentical hematopoietic stem cell transplant for a patient with histiocytic sarcoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Yvette Kasamon (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jennifer A Kanakry; Yvette L Kasamon; Leo Luznik; Lode J Swinnen; HEATHER SYMONS; Hua-Ling Tsai; F. JAVIER BOLANOS MEADE; JANICE DAVIS SPROUL; Ephraim J Fuchs; Nilanjan Ghosh; Douglas E Gladstone; Christopher D Gocke; Richard J Jones; Richard F Ambinder
Outcomes of related donor HLA-identical or HLA-haploidentical allogeneic blood or marrow transplantation for peripheral T cell lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(4):602-6.
2013: Douglas E Gladstone; Richard J Jones; Yvette L Kasamon; Karen E King; Robert A Brodsky; Ephraim J Fuchs; Leo Luznik; Andrea A Zachary; Mary S Leffell
Partially mismatched transplantation and human leukocyte antigen donor-specific antibodies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(4):647-52.
2013: Amer Zeidan; Joseph Aoki; F. JAVIER BOLANOS MEADE; Michael J Borowitz; Ephraim J Fuchs; Richard J Jones; Yvette L Kasamon; Leo Luznik; Lode J Swinnen; HEATHER SYMONS; Richard F Ambinder
Human leukocyte antigen-haploidentical hematopoietic stem cell transplant for a patient with histiocytic sarcoma.
Leukemia & lymphoma 2013;54(3):655-7.
2013: Yvette L Kasamon; William Matsui; B Douglas Smith; Hua-ling Tsai; Richard F Ambinder; F. JAVIER BOLANOS MEADE; Michael J Borowitz; Robert A Brodsky; Hetty Carraway; Steve Y Cho; Pamela Crilley; Douglas E Gladstone; Carol Ann Huff; Richard J Jones; Lode J Swinnen
Brief intensive therapy for older adults with newly diagnosed Burkitt or atypical Burkitt lymphoma/leukemia.
Leukemia & lymphoma 2013;54(3):483-90.
2012: Stephanie Terezakis; Yvette L Kasamon
Tailored strategies for radiation therapy in classical Hodgkin's lymphoma.
Critical reviews in oncology/hematology 2012;84(1):71-84.
2012: Yvette L Kasamon; Kathleen HELEN Burns
Blastic transformation of mantle cell lymphoma.
Blood 2012;120(12):2359.
2012: Yvette L Kasamon; Brian K Link; William Matsui; Brandy Perkins; Leslie L Popplewell; Lode J Swinnen; Douglas E Gladstone; Christopher D Gocke; Thomas M Habermann; JOSEPH HERMAN; Heather A Jacene; Richard J Jones; Richard F Ambinder
Phase 2 study of rituximab-ABVD in classical Hodgkin lymphoma.
Blood 2012;119(18):4129-32.
2012: Douglas E Gladstone; Christopher D Gocke; Constance A Griffin; Amanda Blackford; F. JAVIER BOLANOS MEADE; Eunpi Cho; Yvette L Kasamon; Lode J Swinnen; Richard J Jones
The importance of IGHV mutational status in del(11q) and del(17p) chronic lymphocytic leukemia.
Clinical lymphoma, myeloma & leukemia 2012;12(2):132-7.
2011: Douglas E Gladstone; Carol Ann Huff; Richard J Jones; Yvette L Kasamon; Hyam I Levitsky; Leo Luznik; William Matsui; Jonathan D Powell; Richard F Ambinder; F. JAVIER BOLANOS MEADE; Ivan Borrello; Robert A Brodsky; Ian W Flinn; Ephraim J Fuchs; Marianna Zahurak; Lode J Swinnen
High-dose cyclophosphamide and rituximab without stem cell transplant: a feasibility study for low grade B-cell, transformed and mantle cell lymphomas.
Leukemia & lymphoma 2011;52(11):2076-81.
2011: Douglas E Gladstone; Christopher D Gocke; Constance A Griffin; Yvette L Kasamon; Javier Bolanos Meade; Lode J Swinnen; Amanda Blackford; Richard J Jones
Importance of immunoglobulin heavy chain variable region mutational status in del(13q) chronic lymphocytic leukemia.
Leukemia & lymphoma 2011;52(10):1873-81.
2011: Ashley T Munchel; Yvette L Kasamon; Ephraim J Fuchs
Treatment of hematological malignancies with nonmyeloablative, HLA-haploidentical bone marrow transplantation and high dose, post-transplantation cyclophosphamide.
Best practice & research. Clinical haematology 2011;24(3):359-68.
2011: Ashley Munchel; HEATHER SYMONS; Richard J Jones; Yvette L Kasamon; Chimen Kesserwan; Leo Luznik; Ephraim J Fuchs
Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide.
Pediatric reports 2011;3 Suppl 2():e15.
2011: Yvette L Kasamon; Richard J Jones; Christopher D Gocke; Amanda L Blackford; Eric J Seifter; JANICE DAVIS SPROUL; Steven D Gore; Richard F Ambinder
Extended follow-up of autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide (4-HC) purging for indolent or transformed non-Hodgkin lymphomas.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(3):365-73.
2011: Yvette L Kasamon
Prognostication and Risk-Adapted Therapy of Hodgkin's Lymphoma Using Positron Emission Tomography.
Advances in hematology 2011;2011():271595.
2010: Yvette L Kasamon; Richard J Jones; Robert A Brodsky; Ephraim J Fuchs; William Matsui; Leo Luznik; Jonathan D Powell; Amanda Blackford; Amy Goodrich; Christopher D Gocke; Ross A. Abrams; Richard F Ambinder; Ian W Flinn
Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(6):1203-10.
2010: Leo Luznik; Javier Bolaños-Meade; Marianna Zahurak; Allen R Chen; B Douglas Smith; Robert A Brodsky; Carol Ann Huff; Ivan Borrello; William Matsui; Jonathan D Powell; Yvette L Kasamon; Steven Goodman; Allan Hess; Hyam I Levitsky; Richard F Ambinder; Richard J Jones; Ephraim J Fuchs
High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease.
Blood 2010;115(16):3224-30.
2010: Matthew C Stewart; Yvette L Kasamon
Self-medication and intractable cough.
Journal of hospital medicine : an official publication of the Society of Hospital Medicine 2010;5(4):E30.
2010: Yvette L Kasamon; Leo Luznik; Mary S Leffell; Jeanne Kowalski; Hua-Ling Tsai; F. JAVIER BOLANOS MEADE; Lawrence E Morris; Pamela Crilley; Paul V O'Donnell; Nancy Rossiter; Carol Ann Huff; Robert A Brodsky; William Matsui; Lode J Swinnen; Ivan Borrello; Jonathan D Powell; Richard F Ambinder; Richard J Jones; Ephraim J Fuchs
Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(4):482-9.
2010: B Douglas Smith; Yvette L Kasamon; Jeanne Kowalski; Christopher D Gocke; KATHLEEN MURPHY; Carole B Miller; Elizabeth Garrett-Mayer; Hua-Ling Tsai; LU QIN; Christina Chia; Barbara A Biedrzycki; Thomas C Harding; Guang Haun Tu; Richard J Jones; Kristen Hege; Hyam I Levitsky
K562/GM-CSF immunotherapy reduces tumor burden in chronic myeloid leukemia patients with residual disease on imatinib mesylate.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(1):338-47.
2009: Richard J Jones; Christopher D Gocke; Yvette L Kasamon; Carole B Miller; Brandy Perkins; Jamie P Barber; Milada S Vala; Jonathan Michael Gerber; Lan L Gellert; Mark Siedner; MARIO LEMAS; Sarah Brennan; Richard F Ambinder; William Matsui
Circulating clonotypic B cells in classic Hodgkin lymphoma.
Blood 2009;113(23):5920-6.
2009: Richard L Wahl; Heather A Jacene; Yvette L Kasamon; MARTIN LODGE
From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50 Suppl 1():122S-50S.
2009: F. JAVIER BOLANOS MEADE; Leo Luznik; M Muth; William Matsui; Carol Ann Huff; B Douglas Smith; MOSHE LEVY; Yvette L Kasamon; L J Swinnen; Jonathan D Powell; Robert A Brodsky; Richard F Ambinder; Richard J Jones; Ephraim J Fuchs
Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimen.
Bone marrow transplantation 2009;43(6):477-80.
2009: Yvette L Kasamon; Richard L Wahl; Harvey A Ziessman; Amanda Blackford; Steven Goodman; Caroline A Fidyk; Kathryn M Rogers; F. JAVIER BOLANOS MEADE; Michael J Borowitz; Richard F Ambinder; Richard J Jones; Lode J Swinnen
Phase II study of risk-adapted therapy of newly diagnosed, aggressive non-Hodgkin lymphoma based on midtreatment FDG-PET scanning.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(2):242-8.
2008: Lode J Swinnen; Michael LeBlanc; Thomas M Grogan; Leo I Gordon; Patrick J Stiff; Alan Marshall Miller; Yvette L Kasamon; Thomas P Miller; Richard I Fisher
Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder.
Transplantation 2008;86(2):215-22.
2008: Yvette L Kasamon; Richard F Ambinder
Immunotherapies for Hodgkin's lymphoma.
Critical reviews in oncology/hematology 2008;66(2):135-44.
2008: Yvette L Kasamon; Richard L Wahl
FDG PET and risk-adapted therapy in Hodgkin's and non-Hodgkin's lymphoma.
Current opinion in oncology 2008;20(2):206-19.
2007: F. JAVIER BOLANOS MEADE; Elizabeth Garrett-Mayer; Leo Luznik; Viki Anders; Jennifer Webb; Ephraim J Fuchs; Carol Ann Huff; William Matsui; Ivan Borrello; Robert A Brodsky; Yvette L Kasamon; Lode J Swinnen; Ian W Flinn; Richard F Ambinder; Richard J Jones; Allan Hess; Georgia B Vogelsang
Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(10):1185-91.
2007: Yvette L Kasamon; Ian W Flinn
Management of symptomatic, untreated chronic lymphocytic leukemia.
Blood reviews 2007;21(3):143-56.
2007: Yvette L Kasamon
Blood or marrow transplantation for mantle cell lymphoma.
Current opinion in oncology 2007;19(2):128-35.
2007: Yvette L Kasamon; Richard J Jones; Richard L Wahl
Integrating PET and PET/CT into the risk-adapted therapy of lymphoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48 Suppl 1():19S-27S.
2005: Yvette L Kasamon; Ian W Flinn; Michael R Grever; Louis F Diehl; Elizabeth Garrett-Mayer; Steven Goodman; Margaret S Lucas; John C Byrd
Phase I study of low-dose interleukin-2, fludarabine, and cyclophosphamide for previously untreated indolent lymphoma and chronic lymphocytic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(23):8413-7.
2005: Yvette L Kasamon; Richard F Ambinder
AIDS-related primary central nervous system lymphoma.
Hematology/oncology clinics of North America 2005;19(4):665-87, vi-vii.
2005: Yvette L Kasamon; Richard J Jones; Steven Piantadosi; Richard F Ambinder; Ross A. Abrams; Michael J Borowitz; Candis Morrison; B Douglas Smith; Ian W Flinn
High-dose therapy and blood or marrow transplantation for non-Hodgkin lymphoma with central nervous system involvement.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(2):93-100.
2005: Yvette L Kasamon; Richard J Jones; Louis F Diehl; Hassan Nayer; Michael J Borowitz; Elizabeth Garrett-Mayer; Richard F Ambinder; Ross A. Abrams; Zhe Zhang; Ian W Flinn
Outcomes of autologous and allogeneic blood or marrow transplantation for mantle cell lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(1):39-46.
2004: Yvette L Kasamon; Lode J Swinnen
Treatment advances in adult Burkitt lymphoma and leukemia.
Current opinion in oncology 2004;16(5):429-35.
2004: Yvette L Kasamon; Richard L Wahl; Lode J Swinnen
FDG PET and high-dose therapy for aggressive lymphomas: toward a risk-adapted strategy.
Current opinion in oncology 2004;16(2):100-5.
2003: Tomohide Tatsumi; Lisa S Kierstead; Elena Ranieri; Loreto Gesualdo; Francesco Paolo Schena; James H Finke; Ronald M Bukowski; Vladimir Brusic; John Sidney; Alessandro Sette; Theodore F Logan; Yvette L Kasamon; Craig L Slingluff; John M Kirkwood; Walter J Storkus
MAGE-6 encodes HLA-DRbeta1*0401-presented epitopes recognized by CD4+ T cells from patients with melanoma or renal cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(3):947-54.
2002: Yvette L Kasamon; Thanh N Nguyen; Jennifer A Chan; Alessandra F Nascimento
EBV-associated lymphoma and chronic inflammatory demyelinating polyneuropathy in an adult without overt immunodeficiency.
American journal of hematology 2002;69(4):289-93.
2001: Lisa S Kierstead; Elena Ranieri; Walter Olson; Vladimir Brusic; John Sidney; Alessandro Sette; Yvette L Kasamon; Craig L Slingluff; John M Kirkwood; Walter J Storkus
gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells.
British journal of cancer 2001;85(11):1738-45.
1998: Thomas Tüting; CC Wilson; D M Martin; Yvette L Kasamon; Jennifer L Rowles; D I Ma; Craig L Slingluff; S N Wagner; P van der Bruggen; Joseph Baar; Michael T Lotze; Walter J Storkus
Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alpha.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(3):1139-47.
1996: E Balaban; J S Alper; Yvette L Kasamon
Mean genes and the biology of aggression: a critical review of recent animal and human research.
Journal of neurogenetics 1996;11(1-2):1-43.